Author

Michael J. Walsh

Harvard UniversityORCID 0000-0002-1283-6847Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Birkley S. LimiD· 2 shared Megan T. HoffmaniD· 2 shared Michael Lawrence DouganiD· 2 shared Stephanie K. DouganiD· 2 shared A G MurrayiD· 1 shared Aleigha R. LawlessiD· 1 shared Alfredo Quijano‐RubioiD· 1 shared Andrea GarmillaiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Birkley S. LimORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyScience AdvancesPeer-reviewedNov 7, 2025

Peptide-MHC-targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells

Ellen J.K. Xu, Blake E. Smith, Winiffer D. Conce Alberto…·Michael E. Birnbaum

This study develops pMHC-targeted retroviruses for in vivo gene delivery to tumor-specific T cells, enhancing their expansion and anti-tumor activity in mouse models.

5 citations

mouseCITE-seq

BiochemistryScience ImmunologyPeer-reviewedSep 26, 2025

Potent antitumor activity of a designed interleukin-21 mimic

Jung-Ho Chun, Birkley S. Lim, Suyasha Roy…·David A. Baker

This paper describes a designed IL-21 mimic, 21h10, which shows potent antitumor activity in multiple models and reduces toxicity through TNF blockade.

20 citationstop 2%

humanmouse